
Business
Novo Nordisk Raises Outlook as Wegovy Pill Sales Beat Forecasts
The Danish drugmaker topped expectations on sales and operating profit, lifted its full-year guidance and named a new finance chief.

The Danish drugmaker topped expectations on sales and operating profit, lifted its full-year guidance and named a new finance chief.

Revenue edged past forecasts, but earnings per share fell far short and the core mobility segment declined from a year ago.

The chipmaker's revenue rose 45 percent from a year earlier, driven by demand for its server processors and accelerator chips.